You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metastatic urothelial cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Bicalutamide 150 mg
  • Placebo
  • Québec, Canada
    CHU de Québec - Université Laval
Sep 6, 2023

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Not yet recruiting
  • Urothelial Carcinoma
    • (no location specified)
    Jun 5, 2023

    Avelumab in Real-World Treatment for Advanced or Metastatic

    Not yet recruiting
    • Bladder Cancer
    • (no location specified)
    Nov 21, 2022

    Metastatic Urothelial Cancer Trial in Stockholm (MFA-370)

    Not yet recruiting
    • Metastatic Urothelial Cancer
    • Stockholm, Sweden
      Karolinska University Hospital
    May 19, 2022

    Advanced or Metastatic Urothelium Cancer Trial in Beijing (MRG002, Docetaxel Injection, Paclitaxel Injection)

    Not yet recruiting
    • Advanced or Metastatic Urothelium Cancer
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Feb 22, 2023

    Metastatic Urothelial Cancer in Latin America

    Completed
    • Recurrent/Metastatic Urothelial Cancers
      • Salvador, BA, Brazil
      • +8 more
      Sep 26, 2022

      Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

      Not yet recruiting
      • Locally Advanced Bladder Urothelial Carcinoma
      • +31 more
      • Diagnostic Laboratory Biomarker Analysis
      • Nivolumab
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Metastatic Urothelial Cancer Trial in China (Enfortumab vedotin)

      Active, not recruiting
      • Metastatic Urothelial Cancer
      • Enfortumab vedotin
      • Beijing, China
      • +7 more
      Aug 23, 2022

      Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

      Recruiting
      • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
      • +3 more
      • Cabozantinib S-malate
      • +3 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Aug 8, 2022

      Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

      Not yet recruiting
      • Urothelial Carcinoma
      • +2 more
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center - Philadelphia
      Jun 27, 2023

      Urothelial Cancer Trial (pembrolizumab)

      Completed
      Has Results
      • Urothelial Cancer
      • pembrolizumab
      • (no location specified)
      Aug 18, 2022

      Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

      Active, not recruiting
      • Urothelial Carcinoma
      • Iowa City, Iowa
        University of Iowa Hospitals and Clinics
      Oct 18, 2022

      Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

      Recruiting
      • Locally Advanced Bladder Urothelial Carcinoma
      • +13 more
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Jun 8, 2022

      Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

      Not yet recruiting
      • Metastatic Cancer
      • +5 more
      • (no location specified)
      Jul 10, 2023

      Urothelial Cancer Trial in Spain (Nivolumab, Ipilimumab)

      Recruiting
      • Urothelial Cancer
      • Huelva, Andalucia, Spain
      • +11 more
      Dec 1, 2022

      Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)

      Completed
      • Urothelial/Bladder Cancer, Nos
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Mar 7, 2022

      Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

      Recruiting
      • Locally Advanced Renal Pelvis Urothelial Carcinoma
      • +20 more
      • Duarte, California
      • +16 more
      Aug 10, 2022

      Urothelial Carcinoma Trial in United States (Tremelimumab)

      Active, not recruiting
      • Urothelial Carcinoma
      • Washington, District of Columbia
      • +6 more
      Feb 24, 2022

      Urothelial Carcinoma Trial in China (RC48-ADC)

      Active, not recruiting
      • Urothelial Carcinoma
      • Hefei, Anhui, China
      • +7 more
      Feb 20, 2022

      Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)

      Recruiting
      • Metastatic Urothelial Carcinoma
      • Tampa, Florida
        Moffitt Cancer Center
      Jan 24, 2023

      Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

      Not yet recruiting
      • Urothelial Carcinoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 27, 2023

      Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in

      Recruiting
      • Urothelial Cancer
      • +3 more
      • Sacituzumab Govitecan (SG)
      • Enfortumab vedotin-ejfv (EV)
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Sep 28, 2022

      Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma With Glandular

      Recruiting
      • Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 17, 2021